- Home
- EML vs XBIT Comparison
EML vs XBIT Comparison
Compare EML & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- XBIT
- Stock Information
- Founded
- EML 1858
- XBIT 2005
- Country
- EML United States
- XBIT United States
- Employees
- EML N/A
- XBIT N/A
- Industry
- EML Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- EML Consumer Discretionary
- XBIT Health Care
- Exchange
- EML Nasdaq
- XBIT Nasdaq
- Market Cap
- EML 146.7M
- XBIT 86.3M
- IPO Year
- EML N/A
- XBIT 2015
- Fundamental
- Price
- EML $24.89
- XBIT $2.70
- Analyst Decision
- EML
- XBIT
- Analyst Count
- EML 0
- XBIT 0
- Target Price
- EML N/A
- XBIT N/A
- AVG Volume (30 Days)
- EML 13.2K
- XBIT 52.7K
- Earning Date
- EML 11-04-2025
- XBIT 11-12-2025
- Dividend Yield
- EML 1.75%
- XBIT N/A
- EPS Growth
- EML N/A
- XBIT N/A
- EPS
- EML N/A
- XBIT N/A
- Revenue
- EML $269,054,445.00
- XBIT N/A
- Revenue This Year
- EML $1.56
- XBIT N/A
- Revenue Next Year
- EML $7.00
- XBIT N/A
- P/E Ratio
- EML $14.21
- XBIT N/A
- Revenue Growth
- EML 1.30
- XBIT N/A
- 52 Week Low
- EML $19.06
- XBIT $2.50
- 52 Week High
- EML $35.03
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- EML 57.73
- XBIT 34.08
- Support Level
- EML $23.50
- XBIT $2.72
- Resistance Level
- EML $25.46
- XBIT $3.61
- Average True Range (ATR)
- EML 0.65
- XBIT 0.15
- MACD
- EML 0.13
- XBIT -0.05
- Stochastic Oscillator
- EML 75.68
- XBIT 0.00
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.